Jia, W., Gao, F., Lu, J., Cheng, Z., Dong, X., Shi, X., Su, X., Li, L., Zhang, W., Wang, Y., Ma, J., Li, S., Wang, H., Cheng, L., Mao, L., Jiang, C., Li, Q., Li, X., Zheng, X., Liu, M., Sun, J., Peng, H., Pan, H., Ling, H., Jiang, C., Song, J., Zhang, X., Zhang, L., Liu, Y., Zeng, T., Zhao, Y., Xu, Y., Li, Y., Bao, Y., Zhou, J., Wang, Q. (2026). Efsubaglutide alfa added to metformin improves glycaemia with β-cell functional responses in type 2 diabetes: a randomised, double-blind, placebo-controlled, two-stage adaptive phase 2b/3 trial (SUPER 2). Nature Communications. https://doi.org/10.1038/s41467-026-72574-7